Liver dysfunction in patients with systemic lupus erythematosus

Internal Medicine

Volumn 52, Issue 13, 2013, Pages 1461-1465

  Takahashi, Atsushi ^a   Abe, Kazumichi ^a   Saito, Rie ^a   Iwadate, Haruyo ^a   Okai, Ken ^a   Katsushima, Fumiko ^a   Monoe, Kyoko ^a   Kanno, Yukiko ^a   Saito, Hironobu ^a   Kobayashi, Hiroko ^a   Watanabe, Hiroshi ^a   Ohira, Hiromasa ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti ribosomal P antibody; Autoimmune hepatitis; Liver dysfunction; SLE

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; DOUBLE STRANDED DNA ANTIBODY; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLANGITIS; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIMARY BILIARY CIRRHOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC HEPATITIS; VIRUS HEPATITIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84879627965     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.9458     Document Type: Article

References (25)

1. Cervera R, Khamashta MA, Font J, et al; The European working party of systemic lupus erythematosus. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72: 113-124, 1993.
2. Kojima H, Uemura M, Sakurai S, et al. Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol 37: 617-625, 2002.
3. Miller MH, Urowitz MB, Gladman DD, Blendis LM. The liver in systemic lupus erythematosus. Q J Med 53: 401-409, 1984.
4. Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol 35: 2159-2164, 2008.
5. Takahashi A, Abe K, Yokokawa J, et al. Clinical features of liver dysfunction in collagen disease. Hepatol Res 40: 1092-1097, 2010.
6. Runyon RA, LaBrecque DR, Asuras S. The spectrum of liver disease in SLE. Report of 33 histologically proved cases and review of the literature. Am J Med 69: 187-194, 1980.
7. Huang D, Aghdassi E, Su J, et al. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. J Rheumatol 39: 254-261, 2012.
8. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.
9. Takikawa H, Takamori Y, Kumagi T, et al. Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol Res 27: 192-195, 2003.
10. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
11. Sasaki H, Inoue K, Higuchi K, et al. Primary biliary cirrhosis in Japan: nation survey by the subcommittee on Autoimmune Hepatitis. Gastroenterol Jpn 20: 476-485, 1985.
12. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22: 431-456, 2004.
13. Calamia KT, Balabanova M. Vasculitis in systemic lupus erythematosis. Clin Dermatol 22: 148-156, 2004.
14. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 38: 917-932, 1999.
15. Matsumoto T, Kobayashi S, Shimizu H, et al. The liver in collagen disease: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 20: 366-373, 2000.
16. Matsumoto T, Yoshimine T, Shimouchi K, et al. The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data. Hum Pathol 23: 1151-1158,1992.
17. Hoofnagle JH. Reactivation of hepatitis B. Hepatology 49: s156-s165, 2009.
18. Umemura T, Tanaka E, Kiyosawa K, Kumada H. Japan de novo Hepatitis B Research Group. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis 47: e52-e56, 2008.
19. Tsubouchi H, Kumada H, Kiyosawa K, Kumada H. Japan de novo Hepatitis B Research Group. Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection-joint report of the intractable liver disease study group of japan and the Japanese study group of the standard antiviral therapy for viral hepatitis. Kanzo 50: 38-42, 2009 (in Japanese, Abstract in English).
20. Miyake Y, Iwasaki Y, Terada R, et al. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther 23: 1347-1353, 2006.
21. Arnett FC, Reichlin M. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 99: 465-472, 1995.
22. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Antiribosomal P antibodies in systemic lupus erythematosus: a case control study correlating hepatic and renal disease. Clin Immunol Immunopathol 74: 252-256, 1995.
23. Yoshio T, Masuyama JI, Minota S, et al. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus. J Rheumatol 25: 681-688, 1998.
24. Ohira H, Takiguchi J, Rai T, et al. High frequency of antiribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis. Hepatol Res 28: 137-139, 2004.
25. Toubi E, Shoenfeld Y. Clinical and biological aspects of anti-Pribosomal protein autoantibodies. Autoimmun Rev 6: 119-125, 2007.